Atreya
About Us
Atreya leverages ancient Ayurveda knowledge to pioneer non-invasive solutions for the detection and prevention of diabetes.
The company’s unique value proposition lies in being the first mover to grant patents for non-invasive diabetes detection technology in multiple global regions. Our product uses the concept of Nadi Pariksha, the art performed by palpating arterial flow at vital locations, assessing health, disease patterns (e.g., Diabetes, Hypertension), and mental well-being (e.g., Stress, Anxiety) to provide a predictive prognosis for achieving optimal well-being.
Sector
HealthTech
Website
www.atreyainnovations.com
Location
Pune
Stage
Early
The global diabetes diagnostic market is supposed to be valued at USD 36.6 bn and growing at a CAGR of 9.1% is expected to cross USD 70 Bn by 2032.
The Indian Market in the similar period is showing significant growth. Besides, reports on the Indian Ayurveda market suggest it to grow to USD 26Bn by 2032, growing at a CAGR of 15%.
Opportunity
TEAM
Founder & CEO
An Alumni of IIT Mumbai, and a deep understanding of pulse-based methodology in diagnostics during his time IIT Mumbai.
Co-Founder & CRO
An Alumni of IIT Mumbai, and over a decade of experience in developing products.